WASHINGTON — The Trump administration unveiled four executive orders on Friday aimed at bringing down pharmaceutical prices, a last-ditch effort by the White House to cut drug costs before the November election.
It remains unclear whether the Trump administration is capable of finalizing many of the actions by Election Day — and whether it intends to do so.
Trump backed away Friday from implementing a sweeping policy that would revive a long-stalled plan to cap U.S. drug prices based on what drug makers charge in foreign countries. Instead, he announced a one-month ultimatum for drug manufacturers to propose alternative plans to reduce drug prices.
“We’re going to hold that until August 24, hoping that the pharmaceutical companies will come up with something that will substantially reduce drug prices,” Trump said. “The clock starts right now.”
Print Page
Email to a Friend